Based upon evidence published in peer-reviewed medical literature, the Pritikin Program meets the stringent requirements set forth in Medicare Improvements for Patients and Providers Act (MIPPA) for an ICR program. Pritikin's research supporting CMS' decision included the following:

LDL Cholesterol and Triglycerides Reduced

Among 4,587 adults, LDL decreased on average 23% in 3 weeks. Triglycerides fell 33%. Archives of Internal Medicine, 1991; 151: 1389.New England Journal of Medicine, 1990; 323; 1142.

Chronic Inflammation Reduced

Markers of chronic inflammation, notably C-reactive protein, fell about 40% in 2 to 3 weeks. Atherosclerosis, 2007; 191: 98.Journal of Applied Physiology, 2006; 100: 1657.Metabolism, 2004; 53: 377.

Statin Therapy Enhanced

Before starting the Pritikin Program, 93 people had lowered their cholesterol about 20% using statins. Two weeks after beginning Pritikin, their cholesterol had fallen nearly 20% more. American Journal of Cardiology, 1997; 79: 1112.

Diabetes Improved

Among 864 type 2 diabetics, fasting glucose fell on average 19% within 3 weeks of starting the Pritikin Program. Many reduced their need for diabetes medications. Journal of Applied Physiology, 2005; 98: 3.

Blood Pressure Lowered

Among 1,117 hypertensives, systolic and diastolic blood pressure each fell on average 9% within 3 weeks of beginning the Pritikin Program. Many reduced or eliminated their need for hypertension medications. Journal of Applied Physiology, 2005; 98: 3.

Weight Management

Within 2 to 3 weeks of starting the Pritikin Program, overweight adults lost on average 7 to 11 pounds. Archives of Internal Medicine, 1991; 151: 1389.Journal of CardioMetabolic Syndrome, 2006; 1: 308.

Long-Term Heart Health Success

A follow-up study of 64 heart patients found that 68% of those who had eliminated their angina (chest pain) with the Pritikin Program were still angina-free five years later. Journal of Cardiac Rehabilitation, 1983; 3: 183.


Including the Pritikin Program as a covered ICR program will increase access to ICR services for Medicare beneficiaries and subsequently reduce the disparate impact of heart disease, particularly in minority populations.